Thromboembolism is an unexpected poor response resulting from the use of the tumor necrosis factor inhibitor adalimumab
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2013-06-01
|
| Series: | Научно-практическая ревматология |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/1663 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849399946904600576 |
|---|---|
| author | Yuri Vladimirovich Muravyev G I Gridina D E Karateev |
| author_facet | Yuri Vladimirovich Muravyev G I Gridina D E Karateev |
| author_sort | Yuri Vladimirovich Muravyev |
| collection | DOAJ |
| format | Article |
| id | doaj-art-dd025cb4f54a43f08d1cedb731203067 |
| institution | Kabale University |
| issn | 1995-4484 1995-4492 |
| language | Russian |
| publishDate | 2013-06-01 |
| publisher | IMA PRESS LLC |
| record_format | Article |
| series | Научно-практическая ревматология |
| spelling | doaj-art-dd025cb4f54a43f08d1cedb7312030672025-08-20T03:38:12ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922013-06-0151335435610.14412/1995-4484-2013-15141600Thromboembolism is an unexpected poor response resulting from the use of the tumor necrosis factor inhibitor adalimumabYuri Vladimirovich MuravyevG I GridinaD E Karateevhttps://rsp.mediar-press.net/rsp/article/view/1663 |
| spellingShingle | Yuri Vladimirovich Muravyev G I Gridina D E Karateev Thromboembolism is an unexpected poor response resulting from the use of the tumor necrosis factor inhibitor adalimumab Научно-практическая ревматология |
| title | Thromboembolism is an unexpected poor response resulting from the use of the tumor necrosis factor inhibitor adalimumab |
| title_full | Thromboembolism is an unexpected poor response resulting from the use of the tumor necrosis factor inhibitor adalimumab |
| title_fullStr | Thromboembolism is an unexpected poor response resulting from the use of the tumor necrosis factor inhibitor adalimumab |
| title_full_unstemmed | Thromboembolism is an unexpected poor response resulting from the use of the tumor necrosis factor inhibitor adalimumab |
| title_short | Thromboembolism is an unexpected poor response resulting from the use of the tumor necrosis factor inhibitor adalimumab |
| title_sort | thromboembolism is an unexpected poor response resulting from the use of the tumor necrosis factor inhibitor adalimumab |
| url | https://rsp.mediar-press.net/rsp/article/view/1663 |
| work_keys_str_mv | AT yurivladimirovichmuravyev thromboembolismisanunexpectedpoorresponseresultingfromtheuseofthetumornecrosisfactorinhibitoradalimumab AT gigridina thromboembolismisanunexpectedpoorresponseresultingfromtheuseofthetumornecrosisfactorinhibitoradalimumab AT dekarateev thromboembolismisanunexpectedpoorresponseresultingfromtheuseofthetumornecrosisfactorinhibitoradalimumab |